The National Defense Authorization Act for Fiscal Year 2021 ("the Act") contains a range of policy reforms and requirements that will impact companies doing business with the Government and the supply chain. Many of these measures will be refined through rulemaking.
Among other provisions, the Act:
- Modifies the threshold for the Berry Amendment, which restricts acquisition of certain materials to domestic sources.
- Imposes safeguards to prevent China from acquiring defense-sensitive intellectual property, technology, and data.
- Expands restrictions on the acquisition of certain materials from China, Russia, Iran, and North Korea. Some controls are being phased in over time, which should enable DoD and the defense industrial base ("DIB") to find alternative sources.
- Directs DoD to assess supply chain risks for a list of high-priority items, including microelectronics, medical devices, pharmaceuticals, and aluminum.
- Emphasizes building domestic capacity, including by prioritizing "to the maximum extent practicable" the order of sources for "strategic and critical materials," which are not defined. The conference report directs DoD to increase resiliency by expanding the DIB and fostering industrial cooperation with allies and partners that offer capacity.
- Reflects continuing concern with cost growth on defense programs. "Middle Tier" programs will now receive additional scrutiny.
- Requires identification of the "beneficial owner" of a corporation and mandates that DoD conduct periodic examinations of "covered contractors or subcontractors" to assess compliance with Foreign ownership control or influence ("FOCI") restrictions and requirements.
- Contains cybersecurity provisions that may impact contractors, including cybersecurity assessments that may increase contractors' compliance burdens.
See additional analysis on MayerBrown.com.
Originally Published by Mayer Brown, January 2021
Visit us at mayerbrown.com
Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.
© Copyright 2020. The Mayer Brown Practices. All rights reserved.
This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.